Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Ruppert, P. Mahavadi, T. Mokry, L. Schwertner, M. Korfei, I. Henneke, P. Markart, W. Seeger, A. Günther (Giessen, Germany). Inhibition of napsin A induces proSP-B accumulation and ER-stress: a novel mouse model for lung fibrosis. Eur Respir J 2008; 32: Suppl. 52, 716

Member's Comments

No comment yet.

Related content which might interest you: PBI-compound, a novel first-in-class anti-fibrotic compound, inhibits CTGF and collagen production in murine and human fibroblasts, and reduces lung fibrosis in the bleomycin-induced lung fibrosis model Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013? Year: 2013 Involvement of proteasome inhibition and p53 accumulation in epithelial apoptosis of lung injury Source: Eur Respir J 2005; 26: Suppl. 49, 101s Year: 2005 The enhancement of Stanniocalcin-1 (STC1) secretion increases the ability of mesenchymal stem cells (MSCs) to reduce bleomycin-induced lung fibrosis in a mouse model through inhibition of endoplasmic reticulum stress (ER-stress)/TGFbeta1 pathway Source: International Congress 2014 – ILDs 1 Year: 2014 Regulation of alternative macrophage activation by galectin-3; potential role in lung fibrosis Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009 Increased susceptibility to gammaherpesvirus-induced lung fibrosis of transgenic mice with conditional overexpression of the ER-stress-factor Chop in alveolar epithelium Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease Year: 2019 Extracellular HSP90a promotes pulmonary fibrosis by impairing autophagic flux in lung fibroblasts Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 Expression of the nuclear factor-?B inhibitor A20 is altered in the cystic fibrosis epithelium Source: Eur Respir J 2013; 41: 1315-1323 Year: 2013 Comparison of expression of napsin A and surfactant protein D in bleomycin-induced pulmonary fibrosis mouse model Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Inhibition of the Arp2/3 complex inhibits lung myofibroblast differentiation in vitro and attenuates bleomycin-induced pulmonary fibrosis in mice Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease Year: 2019 Tankyrase(TNKS) inhibiting autophagy promotes the TGF-ß induced EMT process in vitro and Bleomycin(BLM) induced pulmonary fibrosis in rats Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis Year: 2019 ATF3 regulates PINK1 transcription in lung epithelial cells of the aging lung Source: International Congress 2016 – Repair pathways: from lung development to ageing of the lung Year: 2016 Simultaneous inhibition of CTGF and Autotaxin reduces lung fibrosis and improves lung function in mice Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases Year: 2021 Cell specific gene transfer of hepatocyte growth factor reduces bleomycin-induced lung fibrosis by inhibition of partial EMT Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon Year: 2008 Wnt-inducible protein (WISP-1) is a key regulator of alveolar epithelial cell hyperplasia in pulmonary fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 147s Year: 2006 Wnt-inducible protein (WISP-1) is a key regulator of alveolar epithelial cell hyperplasia in pulmonary fibrosis Source: Eur Respir Rev 2006; 15: 180-181 Year: 2006 Expression of the Bcl-2 binding protein beclin 1 in human idiopathic pulmonary fibrosis Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease Year: 2011 High proteasome activity and absence of NF-kB activation in cystic fibrosis cell culture and CF KO mouse models in response to oxidative stress Source: Eur Respir J 2005; 26: Suppl. 49, 403s Year: 2005 Gp130-Stat3 signalling regulates sensitivity to bleomycin induced lung fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 604s Year: 2006 Overexpression of ISCU can extenuate mitochondrial damage, reduce EMT and bleomycin-induced pulmonary fibrosis Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020 Targetingpyruvate kinase M2 isoform inhibits proliferation of human lung fibroblasts Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016